Lumbar Transforaminal Anterior Epidural Steroid Injections in Discogenic Low Back Pain

• Status: Recruiting
• Trial end date: 2022-10-05
• Target enrollment: 0
• Participant gender: All

Summary

Modic changes have been associated with low back pain in many clinical studies and are often considered a part of the disc degeneration process. Modic type 1 change is considered an inflammatory process. The aim of this study is to determine the effectiveness of lumbar transforaminal epidural steroid injections in Modic type-1 changes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Marmara University
• Treatments: Dexamethasone; Lidocaine

Criteria

Inclusion Criteria:

• Being between the ages of 18-65

• Non-radicular, axial back pain

• Lack of response to conservative treatments

• Detection of Modic type 1 changes in contrast-enhanced Lumbar MRI or intervertebral disc findings that may be associated with discogenic pain (nuclear signal intensity change in the disc [black disc], height loss, or high-intensity zone)

Exclusion Criteria:

• Patients younger than 18 and older than 65

• Describing pain radiating to the lower extremity (those with radicular pain)

• Nerve root compression due to disc herniation or other reasons

• Modic changes in more than one level

• Positive facet loading test

• Spinal stenosis or spondylolisthesis

• Diagnosed with spondylodiscitis

• Pregnancy

• Patients with inflammatory rheumatic diseases

• Patients whose use of non-steroidal anti-inflammatory drugs is contraindicated (renal failure, bleeding disorders, etc.)

• Patients with exercise intolerance